Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy
Future Pharmacology · 05.09.2022 · 2 (3) · 360-376
DOI: 10.3390/futurepharmacol2030025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 05.09.2022. Verfasst von Zakiya Gania und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human pluripotent stem cells (hPSCs) have become a powerful tool to generate the various kinds of cell types comprising the human body. Recently, organoid technology has emerged as a platform to generate a physiologically relevant tissue-like structure from PSCs. Compared to an actual human organ, this structure more closely represents a three-dimensional microenvironment than the conventional monolayer culture system for transplantation, disease modeling, and drug development. Despite its advantages, however, the organoid culture system still has various problems related to culture methods, which have become a challenge for attempts to obtain similar physiological properties to their original tissue counterparts. Here, we discuss the current development of organoid culture methods, including the problems that may arise from the currently available culture systems, as well as a possible approach for overcoming their current limitations and improving their optimum utilization for translational application purposes.
Zitieren
APA
Gania, Z., Noorintan, S. T., Septiari, N. P. D. P., Fitriany, D. S., & Torizal, F. G. (2022). Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy. Future Pharmacology, 2(3), 360-376. https://doi.org/10.3390/futurepharmacol2030025
Vancouver
Gania Z, Noorintan ST, Septiari NPDP, Fitriany DS, Torizal FG. Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy. Future Pharmacology. 2022;2(3):360-376. doi:10.3390/futurepharmacol2030025
BibTeX
@article{Gania2022,
author = {Gania, Zakiya and Noorintan, Syarifah Tiara and Septiari, Ni Putu Diah Pradnya and Fitriany, Dhea Sandra and Torizal, Fuad Gandhi},
title = {Strategies for Generating Human Pluripotent Stem Cell-Derived-Organoid Culture for Disease Modeling, Drug Screening, and Regenerative Therapy},
journal = {Future Pharmacology},
year = {2022},
volume = {2},
number = {3},
pages = {360--376},
doi = {10.3390/futurepharmacol2030025}
}
EUVIMED